Расширение терапевтических возможностей с использованием деквалиния хлорида при нарушениях вагинального микробиоценоза

1. Chen J., Tse J., Shi L., Cheng M.M., Lillis R., Near A.M. Real-world clinical burden of patients presenting with vaginitis symptoms in the United States. AJOG Glob. Rep. 2025; 5(2):100504. https://dx.doi.org/10.1016/j.xagr.2025.100504
2. Muzny C.A., Schwebke J.R. Biofilms: An underappreciated mechanism of treatment failure and recurrence in vaginal infections. Clin. Infect. Dis. 2015; 61(4): 601-6. https://dx.doi.org/10.1093/cid/civ353
3. Pelling H., Nzakizwanayo J., Milo S., Denham E.L., MacFarlane W.M., Bock L.J. et al. Bacterial biofilm formation on indwelling urethral catheters. Lett. Appl. Microbiol. 2019; 68(4): 277-93. https://dx.doi.org/10.1111/lam.13144
4. Miquel S., Lagrafeuille R., Souweine B., Forestier C. Anti-biofilm activity as a health issue. Front. Microbiol. 2016; 7: 592. https://dx.doi.org/10.3389/fmicb.2016.00592
5. Mendling W., Weissenbacher E.R., Gerber S., Prasauskas V., Grob P. Use of locally delivered dequalinium chloride in the treatment of vaginal infections: a review. Arch. Gynecol. Obstet. 2016; 293(3): 469-84. https://dx.doi.org/10.1007/s00404-015-3914-8
6. Michaleas S.N., Laios K., Charalabopoulos A., Samonis G., Karamanou M. Joseph Lister (1827-1912): A pioneer of antiseptic surgery. Cureus. 2022; 14(12): e32777. https://dx.doi.org/10.7759/cureus.32777
7. Gaspar C., Rolo J., Cerca N., Palmeira-de-Oliveira R., Martinez-de-Oliveira J., Palmeira-de-Oliveira A. Dequalinium chloride effectively disrupts bacterial vaginosis (BV) Gardnerella spp. biofilms. Pathogens. 2021; 10(3): 261. https://dx.doi.org/10.3390/pathogens10030261
8. Bailly C. Medicinal applications and molecular targets of dequalinium chloride. Biochem. Pharmacol. 2021; 186: 114467. https://dx.doi.org/10.1016/j.bcp.2021.114467
9. Eckel F., Farr A., Deinsberger J., Kernmayer-Farr K., Foessleitner P. Dequalinium chloride for the treatment of vulvovaginal infections: a systematic review and meta-analysis. J. Low Genit. Tract Dis. 2024; 28(1): 76-83. https://dx.doi.org/10.1097/LGT.0000000000000790
10. Vieira-Baptista P., Stockdale C.K., Sobel J., eds. International Society for the Study of Vulvovaginal Disease Recommendations for the Diagnosis and Treatment of Vaginitis [Internet]. Ad Médic, Lda.; 2023. https://dx.doi.org/10.59153/adm.rdtv.001
11. Thamkhantho M., Chayachinda C. Vaginal tablets of dequalinium chloride 10 mg versus clotrimazole 100 mg for vaginal candidiasis: a double-blind, randomized study. Arch. Gynecol. Obstet. 2021; 303(1): 151-60. https://dx.doi.org/10.1007/s00404-020-05784-z
12. Nguyen A.T.C., Le Nguyen N.T., Hoang T.T.A., Nguyen T.T., Tran T.T.Q., Tran D.N.T. et al. Aerobic vaginitis in the third trimester and its impact on pregnancy outcomes. BMC Pregnancy Childbirth. 2022; 22(1): 432. https://dx.doi.org/10.1186/s12884-022-04761-5
13. Donders G., Bellen G., Donders F., Pinget J., Vandevelde I., Michiels T. et al. Improvement of abnormal vaginal flora in Ugandan women by self-testing and short use of intravaginal antimicrobials. Eur. J. Clin. Microbiol. Infect. Dis. 2017; 36(4): 731-8. https://dx.doi.org/10.1007/s10096-016-2856-9
14. Donders G., Bellen G., Grinceviciene S., Ruban K., Vieira-Baptista P. Aerobic vaginitis: no longer a stranger. Res. Microbiol. 2017; 168(9-10): 845-58. https://dx.doi.org/10.1016/j.resmic.2017.04.004
15. Paladine H.L., Desai U.A. Vaginitis: diagnosis and treatment. Am. Fam. Physician. 2018; 97(5): 321-9.
16. Huang S.H., Hsu H.C., Lee T.F., Fan H.M., Tseng C.W., Chen I.H. et al. Prevalence, associated factors, and appropriateness of empirical treatment of trichomoniasis, bacterial vaginosis, and vulvovaginal candidiasis among women with vaginitis. Microbiol. Spectr. 2023; 11(3): e0016123. https://dx.doi.org/10.1128/spectrum.00161-23
17. Миханошина Н.В., Припутневич Т.В., Григорян И.Э. Вагиниты и вагиноз: подходы к диагностике и лечению в свете действующих клинических рекомендаций. Акушерство и гинекология. 2022; 11: 172-8. https://dx.doi.org/10.18565/aig.2022.11.172-178 [Mikhanoshina N.V., Priputnevich T.V., Grigorian I.E. Vaginitis and vaginosis: diagnostic and treatment approaches in the light of the current clinical practice guidelines. Obstetrics and Gynecology. 2022; (11): 172-8 (in Russian). https://dx.doi.org/10.18565/aig.2022.11.172-178].
18. Пустотина О.А. Бактериальный вагиноз: патогенез, диагностика, лечение и профилактика. Акушерство и гинекология. 2018; 3: 150-6. https://dx.doi.org/10.18565/aig.2018.3.150-156 [Pustotina O.A. Bacterial vaginosis: pathogenesis, diagnosis, treatment, and prevention. Obstetrics and Gynecology. 2018; (3): 150-6. (in Russian). https://dx.doi.org/10.18565/aig.2018.3.150-156].
19. Савичева А.М., Тапильская Н.И., Шипицына Е.В., Воробьева Н.Е. Бактериальный вагиноз и аэробный вагинит как основные нарушения баланса вагинальной микрофлоры. Особенности диагностики и терапии. Акушерство и гинекология. 2017; 5: 24-31. https://dx.doi.org/10.18565/aig.2017.5.24-31 [Savicheva A.M., Tapilskaya N.I., Shipitsyna E.V., Vorobyeva N.E. Bacterial vaginosis and aerobic vaginitis as major vaginal microflora balance disorders: Diagnostic and therapeutic characteristics. Obstetrics and Gynecology. 2017; (5): 24-31. (in Russian). https://dx.doi.org/10.18565/aig.2017.5.24-31].
20. Agrawal M., Nigam N., Goel R., Goel J.K., Shukla M. Etiopathogenesis of vaginal discharge among married women in reproductive age group residing in rural area of Bhojipura District, Western Uttar Pradesh. Int. J. Reprod. Contracept. Obstet. Gynecol. 2019; 8(7): 2598. https://dx.doi.org/10.18203/2320-1770.ijrcog20192638
21. Konschuh S., Jayaprakash T., Dolatabadi A., Dayo E., Ramay H., Sycuro L. O02.3 Reclassification of Atopobium vaginae as three novel Fannyhessea species: implications for understanding their role in bacterial vaginosis. Sex. Transm. Infect. 2021; 97(Suppl 1): A18.2-A18. https://dx.doi.org/10.1136/sextrans-2021-sti.58
22. Vaneechoutte M., Guschin A., Van Simaey L., Gansemans Y., Van Nieuwerburgh F., Cools P. Emended description of Gardnerella vaginalis and description of Gardnerella leopoldii sp. nov., Gardnerella piotii sp. nov. and Gardnerella swidsinskii sp. nov., with delineation of 13 genomic species within the genus Gardnerella. Int. J. Syst. Evol. Microbiol. 2019; 69(3): 679-87. https://dx.doi.org/10.1099/ijsem.0.003200
23. Machado D., Castro J., Palmeira-de-Oliveira A., Martinez-de-Oliveira J., Cerca N. Bacterial vaginosis biofilms: challenges to current therapies and emerging solutions. Front. Microbiol. 2016; 6: 1528. https://dx.doi.org/10.3389/fmicb.2015.01528
24. Singh H., Gahane A., Singh V., Ghosh S., Thakur A. Antibiofilm activity of Fmoc-phenylalanine against Gram-positive and Gram-negative bacterial biofilms. J. Antibiot. 2021; 74(6): 407-16. https://dx.doi.org/10.1038/s41429-021-00409-2
25. Vives J.A., Cancelo M.J., Losada M.Á., Doménech A. Dequalinium chloride use in adult Spanish women with bacterial vaginosis: an observational study. J. Obstet. Gynaecol. 2022; 42(1): 103-9. https://dx.doi.org/10.1080/01443615.2020.1867966
26. Larsson P.G., Breding K., Vikström I., Larsson J., Farnebäck M., Hermelin A. A test of cure using a new molecular diagnostic approach for bacterial vaginosis in infected women treated with dequalinium chloride vaginal tablets. J. Womens Health Gyn. 2020; 7: 1-12.
27. Raba G., Ďurkech A., Malík T., Bassfeld D., Grob P., Hurtado-Chong A. et al. Efficacy of dequalinium chloride vs metronidazole for the treatment of bacterial vaginosis: a randomized clinical trial. JAMA Netw. Open. 2024; 7(5): e248661. https://dx.doi.org/10.1001/jamanetworkopen.2024.8661
28. Gonçalves B., Ferreira C., Alves C.T., Henriques M., Azeredo J., Silva S. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit. Rev. Microbiol. 2016; 42(6): 905-27. https://dx.doi.org/10.3109/1040841X.2015.1091805
29. Blostein F., Levin-Sparenberg E., Wagner J., Foxman B. Recurrent vulvovaginal candidiasis. Ann. Epidemiol. 2017; 27(9): 575-582.e3. https://dx.doi.org/10.1016/j.annepidem.2017.08.010
30. Sobel J.D., Sobel R. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species. Exp. Opin. Pharmacother. 2018; 19(9): 971-7. https://dx.doi.org/10.1080/14656566.2018.1476490
31. Подзолкова Н.М., Никитина Т.И. Сравнительная оценка различных схем лечения больных с бактериальным вагинозом и неспецифическим вульвовагинитом. Российский вестник акушера-гинеколога. 2012; 12(5): 72-8. [Podzolkova N.M., Nikitina T.I. Comparative assessment of different treatment regimens for patients with bacterial vaginosis and nonspecific vulvovaginitis. Russian Bulletin of Obstetrician-Gynecologist. 2012; 12(5): 72-8. (in Russian)].
32. Du L., Dong X., Song J., Lei T., Liu X., Lan Y. et al. Temporal and spatial differences in the vaginal microbiome of Chinese healthy women. PeerJ. 2023; 11: e16438. https://dx.doi.org/10.7717/peerj.16438
33. Donders G.G., Vereecken A., Bosmans E., Dekeersmaecker A., Salembier G., Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG. 2002; 109(1): 34-43. https://dx.doi.org/10.1111/j.1471-0528.2002.00432.x
34. Paavonen J., Brunham R.C. Bacterial vaginosis and desquamative inflammatory vaginitis. N Engl. J. Med. 2018; 379(23): 2246-54. https://dx.doi.org/10.1056/NEJMra1808418
35. Радзинский В.Е., Хамошина М.Б., Шеленина Л.А., Климова О.И., Лебедева М.Г., Замотина И.В. Терапия вагинальных инфекций: грани проблемы (международные реалии и российский опыт). Доктор.Ру. 2013; 7(85): 13-7. [Radzinsky V.E., Khamoshina M.B., Shelenina L.A., Klimova O.I., Lebedeva M.G., Zamotina I.V. Vaginal infection treatment: different aspects of the problem (international reality and local experience). Doctor.Ru. 2013; 7(85): 13-7 (in Russian)].
36. Савичева А.М., Тапильская Н.И., Крысанова А.А., Будиловская О.В., Хуснутдинова Т.А., Шалепо К.В. Отдаленные результаты двухэтапного лечения бактериального вагиноза с применением антисептиков и пробиотиков. Акушерство и гинекология: новости, мнения, обучение. 2021; 9(4): 19-28. https://dx.doi.org/10.33029/2303-9698-2021-9-4-19-28 [Savicheva A.M., Tapilskaya N.I., Krysanova A.A., Budilovskaya O.V., Khusnutdinova T.A., Shalepo K.V. Long term results of two stage treatment of bacterial vaginosis using antiseptics and probiotics. Obstetrics and Gynecology: News, Opinions, Training. 2021; 9(4): 19-28. https://dx.doi.org/10.33029/2303-9698-2021-9-4-19-28 (in Russian)].
37. Министерство здравоохранения Российской Федерации. Клинические рекомендации. Воспалительные болезни шейки матки, влагалища и вульвы. 2025. Доступно по: https://cr.minzdrav.gov.ru/preview-cr/989_1 [Ministry of Health of the Russian Federation. Clinical guidelines. Inflammatory diseases of the cervix, vagina and vulva. 2025. Available at: https://cr.minzdrav.gov.ru/preview-cr/989_1 (in Russian)].

Поступила 23.04.2026

Принята в печать 19.06.2026